NASDAQ:MDVL MedAvail (MDVL) Stock Forecast, Price & News $6.00 0.00 (0.00%) (As of 10/2/2023 ET) Add Compare Share Share Today's Range$6.00▼$6.0050-Day Range$0.28▼$11.9952-Week Range$5.19▼$47.50Volume38 shsAverage Volume2,138 shsMarket Capitalization$9.66 millionP/E RatioN/ADividend YieldN/APrice Target$1.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media MedAvail MarketRank™ ForecastAnalyst Rating0.00 Rating ScoreUpside/Downside83.3% Downside$1.00 Price TargetShort InterestHealthy0.50% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.43Based on 2 Articles This WeekInsider TradingSelling Shares$1,727 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.0.78 out of 5 stars 0.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of $1.00, MedAvail has a forecasted downside of 83.3% from its current price of $6.00.Amount of Analyst CoverageMedAvail has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.50% of the float of MedAvail has been sold short.Short Interest Ratio / Days to CoverMedAvail has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in MedAvail has recently increased by 3.51%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldMedAvail does not currently pay a dividend.Dividend GrowthMedAvail does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MDVL. Previous Next 1.9 News and Social Media Coverage News SentimentMedAvail has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for MedAvail this week, compared to 0 articles on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, MedAvail insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,727.00 in company stock.Percentage Held by InsidersOnly 1.50% of the stock of MedAvail is held by insiders. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of MedAvail is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MedAvail is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMedAvail has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About MedAvail (NASDAQ:MDVL) StockMedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona.Read More MDVL Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MDVL Stock News HeadlinesAugust 30, 2023 | finance.yahoo.comMedAvail to Participate in H.C. Wainwright 25th Annual Global Investment ConferenceAugust 16, 2023 | finance.yahoo.comPotential Upside For MedAvail Holdings, Inc. (NASDAQ:MDVL) Not Without RiskOctober 3, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.August 15, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Reports Second Quarter 2023 Financial ResultsAugust 14, 2023 | finance.yahoo.comMedAvail Reports Second Quarter 2023 Financial ResultsAugust 4, 2023 | finance.yahoo.comMedAvail Announces Agreement with Dallas-Based Oak Lawn Pharmacy for Deployment of Ten M4 MedCentersAugust 1, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Announces 1-for-50 Reverse Stock SplitJuly 31, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Announces Enhanced API Integration with its Largest Partner, Texas Health ResourcesOctober 3, 2023 | Behind the Markets (Ad)New Breakthrough "Living Software" Has Been…New Breakthrough "Living Software" Has Been... Ukraine's "Secret Weapon" Against Russia The Washington Post Reports: "It's a big reason David is beating Goliath..." The Wall Street Journal Reports: "it's a technical revolution." Jeff Bezos Said: "It's in the realm of science fiction." Early investors can reap 5,633% gains on the small company revolutionizing warfare >>>July 31, 2023 | finance.yahoo.comMedAvail Announces 1-for-50 Reverse Stock SplitJuly 13, 2023 | finance.yahoo.comMedAvail Announces Enhanced API Integration with its Largest Partner, Texas Health ResourcesJune 21, 2023 | benzinga.comMedAvail Holdings Board Member Awarded $160K Worth of Stock OptionsJune 21, 2023 | benzinga.comMedAvail Holdings Director Awarded $160K Worth of Stock OptionsMay 19, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Reports First Quarter 2023 Financial ResultsMay 18, 2023 | msn.comMedAvail Holdings GAAP EPS of -$0.16, revenue of $0.62MMay 18, 2023 | msn.comMedAvail Holdings: Q1 Earnings InsightsMay 18, 2023 | finance.yahoo.comMedAvail Reports First Quarter 2023 Financial ResultsMay 18, 2023 | finance.yahoo.comMedAvail to Report First Quarter 2023 Financial Results on May 18May 15, 2023 | finance.yahoo.comMedAvail to Report First Quarter 2023 Financial Results on May 15May 15, 2023 | finance.yahoo.comMedAvail Postpones Reporting of First Quarter 2023 Financial ResultsMay 10, 2023 | marketwatch.com8-K: MedAvail Holdings, Inc.April 15, 2023 | finanznachrichten.deMedAvail Holdings, Inc.: MedAvail Reports Fourth Quarter and Full-Year 2022 Financial ResultsApril 13, 2023 | finance.yahoo.comMedAvail Reports Fourth Quarter and Full-Year 2022 Financial ResultsApril 12, 2023 | finance.yahoo.comMedAvail to Report Fourth Quarter and Full Year 2022 Financial Results on April 13March 30, 2023 | finance.yahoo.comMedAvail Postpones Reporting of Fourth Quarter and FY 2022 Financial ResultsMarch 29, 2023 | benzinga.comMedAvail Holdings's Earnings: A PreviewMarch 29, 2023 | markets.businessinsider.comWhat Wall Street expects from MedAvail's earningsSee More Headlines Receive MDVL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter. Email Address MDVL Company Calendar Last Earnings8/14/2023Today10/03/2023Next Earnings (Estimated)11/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Drug stores & proprietary stores Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MDVL CUSIPN/A CIK1402479 Webwww.medavail.com Phone(905) 812-0023Fax973-348-5707Employees279Year FoundedN/APrice Target and Rating Average Stock Price Forecast$1.00 High Stock Price Forecast$1.00 Low Stock Price Forecast$1.00 Forecasted Upside/Downside-83.3%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($28.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-47,620,000.00 Net Margins-192.97% Pretax Margin-157.41% Return on Equity-218.10% Return on Assets-103.45% Debt Debt-to-Equity Ratio0.34 Current Ratio6.34 Quick Ratio4.64 Sales & Book Value Annual Sales$43.11 million Price / Sales0.22 Cash FlowN/A Price / Cash FlowN/A Book Value$13.01 per share Price / Book0.46Miscellaneous Outstanding Shares1,610,000Free Float1,590,000Market Cap$9.66 million OptionableNot Optionable Beta0.54 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Mark Doerr RPh (Age 53)CEO, Pres & Director Comp: $424.42kMs. Ramona Seabaugh (Age 54)CFO, Treasurer & Sec. Comp: $367.94kMs. Joan O'RourkePres of SpotRxMr. Brian SchlerfCorp. ControllerKey CompetitorsAlterity TherapeuticsNASDAQ:ATHEImunonNASDAQ:IMNNLucy Scientific DiscoveryNASDAQ:LSDIAraviveNASDAQ:ARAVAvalon GloboCareNASDAQ:ALBTView All CompetitorsInsiders & InstitutionsRamona SeabaughSold 303 sharesTotal: $1,727.10 ($5.70/share)BlackRock Inc.Sold 68,058 shares on 8/11/2023Ownership: 6.324%Ramona SeabaughSold 3,287 sharesTotal: $1,018.97 ($0.31/share)Mark Edward DoerrSold 72,785 sharesTotal: $22,563.35 ($0.31/share)Mark Edward DoerrSold 20,773 sharesTotal: $6,855.09 ($0.33/share)View All Insider TransactionsView All Institutional Transactions MDVL Stock - Frequently Asked Questions What is MedAvail's stock price forecast for 2023? 0 Wall Street research analysts have issued twelve-month target prices for MedAvail's stock. Their MDVL share price forecasts range from $1.00 to $1.00. On average, they predict the company's share price to reach $1.00 in the next twelve months. This suggests that the stock has a possible downside of 83.3%. View analysts price targets for MDVL or view top-rated stocks among Wall Street analysts. How have MDVL shares performed in 2023? MedAvail's stock was trading at $0.2998 at the start of the year. Since then, MDVL stock has increased by 1,901.3% and is now trading at $6.00. View the best growth stocks for 2023 here. When is MedAvail's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023. View our MDVL earnings forecast. How were MedAvail's earnings last quarter? MedAvail Holdings, Inc. (NASDAQ:MDVL) issued its earnings results on Monday, August, 14th. The company reported ($3.06) EPS for the quarter. The business had revenue of $0.41 million for the quarter. MedAvail had a negative trailing twelve-month return on equity of 218.10% and a negative net margin of 192.97%. What is MedAvail's stock symbol? MedAvail trades on the NASDAQ under the ticker symbol "MDVL." How do I buy shares of MedAvail? Shares of MDVL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is MedAvail's stock price today? One share of MDVL stock can currently be purchased for approximately $6.00. How much money does MedAvail make? MedAvail (NASDAQ:MDVL) has a market capitalization of $9.66 million and generates $43.11 million in revenue each year. The company earns $-47,620,000.00 in net income (profit) each year or ($28.72) on an earnings per share basis. How many employees does MedAvail have? The company employs 279 workers across the globe. How can I contact MedAvail? MedAvail's mailing address is 45 HORSEHILL ROAD SUITE 106, CEDAR KNOLLS NJ, 07927. The official website for the company is www.medavail.com. The company can be reached via phone at (905) 812-0023, via email at jgoodford@myoscorp.com, or via fax at 973-348-5707. This page (NASDAQ:MDVL) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedAvail Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.